Relay Therapeutics (market cap: $748.2 million), a biotechnology company focused on developing innovative cancer therapies, has been making significant strides in the competitive landscape of ...
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.
12h
The college said the So Hot Right Now conference, whose headline speaker is high-profile British GP Louise Newson, was no ...
In the last few months, some unscrupulous elements have intensified their illegal operations across the country, freely circulating fake and substandard drugs as well as unwholesome food and drinks.
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback